hims semaglutide results & Hers launched a $49 weight loss pill last week, offering a compounded version of semaglutide, the active ingredient in FDA approved drugs like Wegovy. Just 48 hours later, the company Hims: Why The Semaglutide Shortage

dbGSH: A database of S-glutathionylation

Approximately 90% of the body serotonin resides in the gut, produced by enterochromaffin cells in the intestinal lining

In one third of patients, two doses are required to cover the 24h period

The majority of patients experience significant weight regain if treatment with GLP-1 medications stops, and it is unclear if there will be a sustainable, long-term access to GLP-1 treatment for obesity for Medicare beneficiaries. Nielsen says she anticipates demand for the GLP-1 Bridge program will be high, making it important to see your healthcare provider for an evaluation now

Always administered by a licensed professional